Selskabets formål er at drive handel, fabrikation og industri samt anden dermed beslægtet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 361.2 mio. | 7.8 mio. | 103.1 mio. | 22.9 mio. | 47 | |
CVR: 20575778
Secondary names: SYNGENTA A/S, SYNGENTA AGRO A/S, NOVARTIS AGRI A/S
Companies in the same industry and area
CVR 16959995
CVR 46124383
CVR 46344545
CVR 12938241
CVR 25859898
Compared to 182 companies in Engroshandel med kemiske produkter
Comparison is based on industry median values
The financial health of SYNGENTA NORDICS A/S shows signs of decline, with revenue decreasing from 427.2 million DKK in 2022 to 361.2 million DKK in 2024, while profit also fell from 13.99 million DKK in 2023 to 7.84 million DKK in 2024. The company's equity has also decreased significantly from 31 million DKK in 2022 to 22.85 million DKK in 2024, indicating potential concerns regarding its financial stability. Despite a solid revenue base, the declining profit margins and equity position suggest challenges ahead. As a player in the chemical products wholesale industry, maintaining profitability and addressing these equity concerns will be crucial for sustaining its market position.
AI-generated summary